These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 22032557

  • 1. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.
    Terpos E, Fragiadaki K, Konsta M, Bratengeier C, Papatheodorou A, Sfikakis PP.
    Clin Exp Rheumatol; 2011; 29(6):921-5. PubMed ID: 22032557
    [Abstract] [Full Text] [Related]

  • 2. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
    Karsdal MA, Schett G, Emery P, Harari O, Byrjalsen I, Kenwright A, Bay-Jensen AC, Platt A.
    Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
    [Abstract] [Full Text] [Related]

  • 3. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis.
    Świerkot J, Gruszecka K, Matuszewska A, Wiland P.
    Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):397-404. PubMed ID: 25837853
    [Abstract] [Full Text] [Related]

  • 4. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
    Anastasilakis AD, Polyzos SA, Gkiomisi A, Bisbinas I, Gerou S, Makras P.
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
    [Abstract] [Full Text] [Related]

  • 5. Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
    Terpos E, Heath DJ, Rahemtulla A, Zervas K, Chantry A, Anagnostopoulos A, Pouli A, Katodritou E, Verrou E, Vervessou EC, Dimopoulos MA, Croucher PI.
    Br J Haematol; 2006 Dec; 135(5):688-92. PubMed ID: 17107351
    [Abstract] [Full Text] [Related]

  • 6. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
    Garnero P, Thompson E, Woodworth T, Smolen JS.
    Arthritis Rheum; 2010 Jan; 62(1):33-43. PubMed ID: 20039425
    [Abstract] [Full Text] [Related]

  • 7. Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use.
    Lim MJ, Kwon SR, Joo K, Son MJ, Park SG, Park W.
    Korean J Intern Med; 2014 Nov; 29(6):807-13. PubMed ID: 25378980
    [Abstract] [Full Text] [Related]

  • 8. Effects of iguratimod on the levels of circulating regulators of bone remodeling and bone remodeling markers in patients with rheumatoid arthritis.
    Wang X, Ma C, Li P, Zhao F, Bi L.
    Clin Rheumatol; 2017 Jun; 36(6):1369-1377. PubMed ID: 28474138
    [Abstract] [Full Text] [Related]

  • 9. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
    Folestad A, Ålund M, Asteberg S, Fowelin J, Aurell Y, Göthlin J, Cassuto J.
    Acta Orthop; 2015 Jun; 86(4):415-25. PubMed ID: 25811776
    [Abstract] [Full Text] [Related]

  • 10. Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study.
    Fassio A, Adami G, Giollo A, Viapiana O, Malavolta N, Saviola G, Bortolotti R, Idolazzi L, Bertoldo F, Rossini M, Gatti D.
    Calcif Tissue Int; 2020 Apr; 106(4):371-377. PubMed ID: 31897527
    [Abstract] [Full Text] [Related]

  • 11. Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study.
    Catalano A, Loddo S, Bellone F, Pecora C, Lasco A, Morabito N.
    Bone; 2018 Nov; 116():42-46. PubMed ID: 30010081
    [Abstract] [Full Text] [Related]

  • 12. The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis.
    Briot K, Rouanet S, Schaeverbeke T, Etchepare F, Gaudin P, Perdriger A, Vray M, Steinberg G, Roux C.
    Joint Bone Spine; 2015 Mar; 82(2):109-15. PubMed ID: 25557658
    [Abstract] [Full Text] [Related]

  • 13. Serum concentrations of sclerostin and bone turnover markers in children with cow's milk allergy.
    Ambroszkiewicz J, Rowicka G, Chełchowska M, Gajewska J, Strucińska M, Laskowska-Klita T.
    Med Wieku Rozwoj; 2013 Mar; 17(3):246-52. PubMed ID: 24296448
    [Abstract] [Full Text] [Related]

  • 14. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I, Balon BP, Rus I, Marc J.
    Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
    [Abstract] [Full Text] [Related]

  • 15. The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.
    Polyzos SA, Anastasilakis AD, Efstathiadou Z, Kita M, Litsas I, Avramidis A, Arsos G, Moralidis E, Gerou S, Pavlidou V, Papatheodorou A, Terpos E.
    Horm Metab Res; 2009 Nov; 41(11):846-50. PubMed ID: 19670154
    [Abstract] [Full Text] [Related]

  • 16. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
    Piatek S, Adolf D, Wex T, Halangk W, Klose S, Westphal S, Amthauer H, Winckler S.
    Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
    [Abstract] [Full Text] [Related]

  • 17. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH, Lee HJ, Sung IH, Kim TH.
    J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
    [Abstract] [Full Text] [Related]

  • 18. Physical training increases osteoprotegerin in postmenopausal women.
    Bergström I, Parini P, Gustafsson SA, Andersson G, Brinck J.
    J Bone Miner Metab; 2012 Mar; 30(2):202-7. PubMed ID: 21823052
    [Abstract] [Full Text] [Related]

  • 19. Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis.
    Ambroszkiewicz J, Sands D, Gajewska J, Chelchowska M, Laskowska-Klita T.
    Adv Med Sci; 2013 Mar; 58(2):338-43. PubMed ID: 24277958
    [Abstract] [Full Text] [Related]

  • 20. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
    Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Koike T, Nakamura H.
    Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.